Patents Examined by Lila Peisee
  • Patent number: 5827823
    Abstract: Infusions of brain-derived neurotrophic factor, neurotrophin-3 or neurotrophin-4 are used to produce analgesia in mammals. In addition, these neurotrophins are used to treat other diseases or disorders mediated by serotonin.
    Type: Grant
    Filed: January 25, 1995
    Date of Patent: October 27, 1998
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Judith Siuciak, Charles A. Altar, Ronald M. Lindsay